all report title image

ANDROSTENEDIONE MARKET ANALYSIS

Androstenedione Market, by Product Type (Androstenedione (4-AD), Androstadienedione (ADD), and Others), by Application (Arthritis, Infectious Inflammation, Fertility Control, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI2634
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Challenges And Opportunities

However, stringent government regulations is major factor restraining growth of the global androstenedione market. For instance, androstenedione is banned by the World Anti-Doping Agency (WADA) and International Olympic Committee (IOC), under the category of androgenic anabolic steroids. However, adverse effects of androstenedione include sustained increase in serum estrogen and increase in serum luteinizing hormone, lean muscle mass, and bone growth problem in children, thus restraining growth of the global androstenedione market. Furthermore, pregnant women are warned from using these pills as they are linked with higher risks of labor and cause of miscarriage.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.